Overview

Theophylline in Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This will be a prospective randomized double-blinded parallel group clinical trial evaluating the short-term effects of theophylline therapy on exercise duration and lung function in patients with chronic obstructive pulmonary disease already receiving both tiotropium and a long-acting beta-agonist (salmeterol or formoterol).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborator:
Ontario Lung Association
Treatments:
Theophylline